GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kabra Drugs Ltd (BOM:524322) » Definitions » YoY Rev. per Sh. Growth

Kabra Drugs (BOM:524322) YoY Rev. per Sh. Growth : 0.00% (As of Sep. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Kabra Drugs YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Kabra Drugs's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 was 0.00%.

Kabra Drugs's Revenue per Share for the three months ended in Sep. 2024 was ₹0.00.

Kabra Drugs YoY Rev. per Sh. Growth Historical Data

The historical data trend for Kabra Drugs's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kabra Drugs YoY Rev. per Sh. Growth Chart

Kabra Drugs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Kabra Drugs Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kabra Drugs YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Kabra Drugs's YoY Rev. per Sh. Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY Rev. per Sh. Growth (A: Mar. 2024 )
=(Revenue per Share (A: Mar. 2024 )-Revenue per Share (A: Mar. 2023 ))/ | Revenue per Share (A: Mar. 2023 ) |
=(0-0)/ | 0 |
=N/A %

Kabra Drugs's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Sep. 2024 )
=(Revenue per Share (Q: Sep. 2024 )-Revenue per Share (Q: Sep. 2023 )) / | Revenue per Share (Q: Sep. 2023 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kabra Drugs YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Kabra Drugs's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Kabra Drugs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kabra Drugs Ltd (BOM:524322) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
BOM:524590 BOM:540108 BOM:539680 BOM:530207 BOM:524516 BOM:531686 BOM:524661 BOM:543444 BOM:531541 BOM:531762 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 3, Swaminathan Street, 2nd Floor, West Mambalam, Chennai, TN, IND, 600 033
Website
http://www.kabradrugs.com
Kabra Drugs Ltd is an India-based drug manufacturing company. It is engaged in the business of Permaculture manufacturing and trading in pharma related products. Geographically, all the company operations are carried out in India. The company's drug manufacturing plant is located in Madhya Pradesh, India. Its products include Cardiovascular Drugs, Anti-Infective Drugs, Oncology Drugs, Gastroenterologic Drugs, Hormonal Drugs, etc.

Kabra Drugs Headlines

No Headlines